ProKidney Corp. (PROK) NASDAQ

2.71

+0.02(+0.74%)

Updated at July 31 10:19AM

Currency In USD

Valuation

Market Cap165.48M
Enterprise Value69.59M
P/E Ratio-5.07
PEG Ratio-1.06
Price/Sales Ratio5,864.73
Price/Book Ratio-0.35
Enterprise/Revenue5,556.11
Enterprise/EBITDA-10.62

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-223.62
Operating Margin-604.54

Management Effectiveness

Return On Assets-0.17
Return On Equity0.07

Income Statement

Revenue76,000
Revenue/Share0
Gross Profit76,000
EBITDA-158.49M
Net Income-61.19M
Diluted EPS-0.62

Balance Sheet

Total Cash328.5M
Total Cash/Share2.55
Total Debt3.37M
Total Debt/Equity-0
Current Ratio10.96
Book Value Per Share2.87

Price History

52-Week Change14.96
52-Week High7.13
52-Week Low0.46
Moving Average 50 Days1.7
Moving Average 200 Days1.49

Statistics

Average Volume12.99M
Shares Outstanding129.53M
% Held by Institutions37.21

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A